Agios Pharmaceuticals | AGIO - 借入資本

株価
28.05
毎日の変更
0 0%
毎月
-17.09%
毎年
-9.34%
Q2 予測
24.78




借入資本 変化する 日付
AbbVie USD 58.94B 4.03B 2025-12
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
Amgen USD 50B 2.43B 2025-12
Arrowhead Research USD 538.1M 323.22M 2025-12
Astellas Pharma JPY 320B 0 2026-03
AstraZeneca USD 25.96B 177M 2026-03
Bayer EUR 31.83B 877M 2025-12
Biogen USD 6.29B 1.7M 2026-03
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Daiichi Sankyo JPY 300.15B 199.41B 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Gilead Sciences USD 22.13B 6M 2025-12
GlaxoSmithKline GBP 14.01B 696M 2026-03
Incyte USD 29.41M 785K 2026-03
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
Merck USD 39.97B 6B 2025-09
Moderna USD 610M 584M 2025-12
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Novartis USD 29.59B 5.35B 2025-12
Novartis USD 29.59B 5.35B 2025-12
Pfizer USD 57.41B 93M 2025-09
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03